Filings received so far for Q3 2026: 49 13F filers report a position in LONA shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Spruce Street Capital LP and 2 other reporting persons reported 393,700 LONA shares, 4.2% of the class, as of 2026-09-30, in a 13G filed 2026-11-13. 0000902664-26-004525
Accepted , ingested
GREAT POINT PARTNERS LLC and 2 other reporting persons reported 474,345 LONA shares, 5.03% of the class, as of 2026-10-28, in a 13G filed 2026-11-04. 0001172661-26-004856
Accepted , ingested
Portman David J. bought 3,149,470 LONA shares on 2026-10-26, Form 4 filed 2026-10-28. 0002126186-26-000002
Accepted , ingested
Sermonix Pharmaceuticals, Inc. and 1 other reporting person reported 3,149,470 LONA shares, 25.1% of the class, as of 2026-10-26, in a 13D/A filed 2026-10-28. 0001655566-26-000004
Accepted , ingested
PERCEPTIVE ADVISORS LLC and 2 other reporting persons acquired 776,648 LONA shares on 2026-10-26, Form 4 filed 2026-10-26. 0001193125-26-431896
Accepted , ingested
PERCEPTIVE ADVISORS LLC and 3 other reporting persons reported 1,889,403 LONA shares, 19.99% of the class, as of 2026-10-26, in a 13D/A filed 2026-10-26. 0001193125-26-431897